HealthDay News — An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and older with untreated hypertension ...

Increase seen in lifetime use among adults and adolescents; past-year use higher among young adults, older adults.

At Sensient Technologies, one of the world’s largest dyemakers, scientists are working hard to find natural alternatives.

For children with sickle cell anemia (SCA), hydroxyurea has sustained clinical benefits in terms of reducing emergency department visits and hospital days, acco ...

Older patients have divergent immune phenotypes at baseline that persist during immune checkpoint inhibitor therapy.

Neoadjuvant PD-1 blockade with dostarlimab enables nonoperative management strategy for large proportion of patients.

Outbreak mainly affected members of communities with low measles vaccination coverage in New Mexico, Oklahoma, and Texas.

NIH Director Dr Jay Bhattacharya previously announced plans to develop "national disease registries, including a new one for autism" as part of a larger research effort.

The FDA has approved Zevaskyn (prademagene zamikeracel) for the treatment of recessive dystrophic epidermolysis bullosa, a rare genetic skin disorder.

Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy ® (semaglutide).

The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 SELECT-GCA trial.

Tepylute is indicated for the treatment of adenocarcinoma of the breast or ovary . It is now supplied as a multiple-dose vial containing 100mg of thiotepa, in addition to the previously approved ...